Healthcare Musings: Can the HKEX Be No.1 in Biotech?
A macro view. by Vanessa Huang Charles Li’s vision that HKEX can be the largest biotech IPO venue in the next five to ten years may sound ambitious, but when we look at the numbers and the context...
